We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
22 hedge funds and large institutions have $15.9M invested in Cardiff Oncology in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more capital invested
Capital invested by funds: $12.3M → $15.9M (+$3.61M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
5% more funds holding
Funds holding: 21 → 22 (+1)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$441K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.9K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$53.3K |
| 4 |
PG
PEAK6 Group
Chicago,
Illinois
|
+$36.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17.4K |
